Print Page

Letters to Healthcare Providers
 
Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months in the United Kingdom, including additional oversight on initiation of treatment for patients under 18 years (Letter to Healthcare Professionals)
 
 
 
Attachment:
  1. Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months, including additional oversight on initiation of treatment for patients under 18 years  
Related Information:
The United Kingdom: Isotretinoin – changes to prescribing guidance and additiona... Posted 2026-01-23
中國：國家藥監局關於修訂異維A酸軟膠囊說明書的公告（2026年第2號）(Chinese only) Posted 2026-01-07
Australia: New safety warnings for isotretinoin (Roaccutane) Posted 2025-04-08
Canada: Summary Safety Review: Isotretinoin: Assessing the potential risk of sex... Posted 2024-07-26
Singapore: HSA: Isotretinoin and risk of psychiatric disorders and sexual dysfun... Posted 2023-12-16
The United Kingdom: Isotretinoin (Roaccutane▼): introduction of new safety measu... Posted 2023-11-01
The United Kingdom: Isotretinoin (Roaccutane▼): new safety measures to be introd... Posted 2023-04-27
The United Kingdom: Isotretinoin: an expert review of suspected psychiatric and ... Posted 2020-11-11
The United Kingdom: Isotretinoin (Roaccutane▼): reminder of important risks and ... Posted 2020-08-27
The United Kingdom: Isotretinoin (Roaccutane): rare reports of erectile dysfunct... Posted 2017-10-27
Isotretinoin (Roaccutane): rare reports of erectile dysfunction and decreased li... Posted 2017-10-27
Canada: Health Canada reinforces the importance of preventing pregnancy while ta... Posted 2016-09-08
 
back